A record of what JM Financial Analysis said publicly, with the source. Not advice.
“JM Financial has a 'Buy' call on Sun Pharmaceutical Industries with a 12-month target price of Rs 2,115, up from the current Rs 1,655.2. The rationale includes a strong specialty pipeline, potential M&A deals as cash piles rise, and increasing specialty contribution, which is expected to keep valuation multiples elevated.”
JM Financial Analysis’s track record (trackable calls only): 213 graded calls · 95% CI 41–54%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
No entry price is stated, so the call starts at the first close after it was published.
Target ₹2,115, as stated.
Window: 12 months, the time frame the call states ("12-month").
Neither the target ₹2,115 was reached on a close by the end of the window. Miss.
The grader’s working: R4 TARGET_CALL: entered ₹1613.6 on 2025-02-25 (next trading session's close); neither target nor stop reached by window end 2026-02-24. Window 365 days — rule H1: the quote states "12-month".